Literature DB >> 8982629

Neisseria gonorrhoeae RNA/DNA hybridization and culture for screening of gonococcal infections in a low-prevalence population.

P Sednaoui1, J E Malkin, J M Alonso.   

Abstract

Gonorrhea is still a major sexually transmitted disease (STD) worldwide. Its etiologic diagnosis is based on identification of the causative agent, Neisseria gonorrhoeae, by culture of genital secretions, which is often hampered by difficulties of sample collection and transport. Alternatively, nucleic acid hybridization techniques for routine diagnosis of N. gonorrhoeae appear to be useful by eliminating problems associated with bacterial viability, particularly for surveillance of low-prevalence populations. Our study among 1,508 outpatients undergoing routine examination for common STDs used RNA/DNA hybridization with a DNA probe specific for N. gonorrhoeae (Gen Probe Pace 2) and classical culture. Of the 1,750 specimens tested, 12 were positive by DNA probe and culture. In 8 cases, only DNA probe was positive while culture was negative. In 3 of these discrepant cases clinical and epidemiological data suggested true N. gonorrhoeae infection. Thus, DNA probe assay for N. gonorrhoeae may greatly improve screening of N. gonorrhoeae among low-prevalence populations. However, culture remains mandatory for testing antimicrobial resistance of these highly communicable infectious agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982629     DOI: 10.1007/bf00499468

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  9 in total

1.  Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory.

Authors:  R J Limberger; R Biega; A Evancoe; L McCarthy; L Slivienski; M Kirkwood
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Use of the Gen-Probe PACE system for the detection of Neisseria gonorrhoeae in urogenital samples.

Authors:  P A Granato; M R Franz
Journal:  Diagn Microbiol Infect Dis       Date:  1990 May-Jun       Impact factor: 2.803

3.  Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories.

Authors:  Y M Hale; M E Melton; J S Lewis; D E Willis
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

4.  DNA probe confirmatory test for Neisseria gonorrhoeae.

Authors:  J S Lewis; D Kranig-Brown; D A Trainor
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

5.  Comparison of DNA-probe test and culture for the detection of Neisseria gonorrhoeae in genital samples.

Authors:  A Stary; W Kopp; B Zahel; S Nerad; L Teodorowicz; I Hörting-Müller
Journal:  Sex Transm Dis       Date:  1993 Sep-Oct       Impact factor: 2.830

6.  Comparison of Gen-Probe DNA probe test and culture for the detection of Neisseria gonorrhoeae in endocervical specimens.

Authors:  E S Panke; L I Yang; P A Leist; P Magevney; R J Fry; R F Lee
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

7.  DNA hybridization technique for the detection of Neisseria gonorrhoeae in men with urethritis.

Authors:  P A Totten; K K Holmes; H H Handsfield; J S Knapp; P L Perine; S Falkow
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

8.  Value of a DNA probe assay (Gen-Probe) compared with that of culture for diagnosis of gonococcal infection.

Authors:  F Vlaspolder; J A Mutsaers; F Blog; A Notowicz
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

Review 9.  Gonococcal infections.

Authors:  E W Hook; K K Holmes
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.